Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iulia Iatan

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Lipidology|November 5, 2023
Sex differences in the perception of cardiovascular risk in familial hypercholesterolemiaBalaqis Alshibani, Iulia Iatan, Amanda Guerin, et al.
European Journal of Preventive Cardiology|June 13, 2025
Rationale for the Routine Screening of Lipoprotein (a) in Cardiovascular Risk AssessmentIulia Iatan, Marlys L Koschinsky, Logan Trenaman, et al.
The Lancet. Diabetes & Endocrinology|October 25, 2025
Recent advances in research and care of familial hypercholesterolaemiaRaul D Santos, Samuel S Gidding, Mafalda Bourbon, et al.
Biochemistry|December 7, 2007
Carboxyl-terminal disulfide bond of acid sphingomyelinase is critical for its secretion and enzymatic functionChing Yin Lee, Taku Tamura, Nadia Rabah, et al.
Circulation. Cardiovascular Genetics|August 28, 2012
Exome sequencing identifies 2 rare variants for low high-density lipoprotein cholesterol in an extended familyM V Prasad Linga Reddy, Iulia Iatan, Daphna Weissglas-Volkov, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levelsIulia Iatan, Zari Dastani, Ron Do, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Atherosclerosis|November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaborationG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Lipidology|November 5, 2023
Sex differences in the perception of cardiovascular risk in familial hypercholesterolemiaBalaqis Alshibani, Iulia Iatan, Amanda Guerin, et al.
European Journal of Preventive Cardiology|June 13, 2025
Rationale for the Routine Screening of Lipoprotein (a) in Cardiovascular Risk AssessmentIulia Iatan, Marlys L Koschinsky, Logan Trenaman, et al.
The Lancet. Diabetes & Endocrinology|October 25, 2025
Recent advances in research and care of familial hypercholesterolaemiaRaul D Santos, Samuel S Gidding, Mafalda Bourbon, et al.
Biochemistry|December 7, 2007
Carboxyl-terminal disulfide bond of acid sphingomyelinase is critical for its secretion and enzymatic functionChing Yin Lee, Taku Tamura, Nadia Rabah, et al.
Circulation. Cardiovascular Genetics|August 28, 2012
Exome sequencing identifies 2 rare variants for low high-density lipoprotein cholesterol in an extended familyM V Prasad Linga Reddy, Iulia Iatan, Daphna Weissglas-Volkov, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levelsIulia Iatan, Zari Dastani, Ron Do, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Atherosclerosis|November 23, 2025
Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaborationG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Pageof 4